(Photo not available)
Andrew Czarnik’s Illumina Offers Genotyping Technology to Enhance Preventive Medicine
By: Kristina Russell, B.S. in Advertising, College of Media, Class of 2010
Andrew Czarnik is a co-founder of San-Diego-based Illumina, which launched its first system, the Illumina BeadLab, in 2002. Illumina technologies are used by a broad range of academic, government, and pharmaceutical clients as well as biotechnology institutes around the globe. In 2009, Illumina announced the launch of its own personal full genome sequencing service. Dr. Czarnik’s methods will be useful in improving preventive medicine. To this end, personal genomes can be used to ensure that patients get the medicine that is most likely to work for them. In 2007 Czarnik also started Solexa, Inc., a company that develops and commercializes genetic analysis technologies, and he serves as manager for the Reno, Nevada-based Protia, LLC, which he founded in 2003.
Andrew Czarnik grew up in Appleton, WI and earned his B.S. (cum laude) in Biochemistry from the University of Wisconsin-Madison. Czarnik continued his education at the University of Illinois, where he earned an M.S. in Biochemistry in 1980 and a Ph.D. in Organic Chemistry in 1981. Czarnik did his postdoctoral work at Columbia University and in 1983 began teaching Chemistry at Ohio State University, before turning to the commercialization of his research ideas.
Dr. Czarnik continues to conduct research on sensor discovery and molecule intervention. He has devoted his life to research and development that will lead to the creation of new products and innovations that will advance the world of medicine.